GlassScriptPhysician profile
Shyam Kishan
NPI 1689644528
$203,467.03
in general payments reported to CMS, 2019-2025
10 companies · $26K in 2025
The $26K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $29K · 2021: $37K · 2022: $35K · 2023: $26K · 2024: $23K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $74K · Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $73,797.85 |
| Food and Beverage | $589.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $185,661.26 | 2019-2025 | Reflect/Reflect Hde, Reflect, Marvel Growing Rod |
| Stryker Corporation | $16,189.01 | 2019-2024 | Denali Spinal System, Insignia |
| Zimmer Biomet Holdings, INC. | $972.15 | 2020 | |
| Pylant Medical | $241.07 | 2020-2025 | |
| Depuy Synthes Sales INC. | $171.19 | 2019-2025 | X-Pac, Na, Expedium |
| Medtronic, INC. | $103.74 | 2021 | |
| Vb Spine LLC | $56.69 | 2025 | Denali Spinal System |
| Abbott Laboratories | $38.26 | 2022 | |
| Zimvie INC. | $17.64 | 2022 | |
| Acera Surgical, INC. | $16.02 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shyam Kishan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.